Immunogenicity and safety of 1 vs 2 doses of quadrivalent meningococcal conjugate vaccine in youth infected with human immunodeficiency virus

Journal of Pediatrics

Volumn 161, Issue 4, 2012, Pages

  Lujan Zilbermann, Jorge ^a   Warshaw, Meredith G ^b   Williams, Paige L ^b   Spector, Stephen A ^c   Decker, Michael D ^d   Abzug, Mark J ^e   Heckman, Barb ^f   Manzella, Adam ^f   Kabat, Bill ^g   Jean Philippe, Patrick ^h   Nachman, Sharon ⁱ   Siberry, George K ^j  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b CENTER FOR BIOSTATISTICS IN AIDS RESEARCH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d SANOFI PASTEUR   (France)

^e UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^f FRONTIER SCIENCE AND TECHNOLOGY RESEARCH FOUNDATION   (United States)

^g CHILDREN'S MEMORIAL HOSPITAL   (United States)

^h NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

ⁱ STONY BROOK UNIVERSITY   (United States)

^j EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; MENINGOCOCCUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; BLOOD GROUP TYPING; CHILD; DISEASE SEVERITY; DRUG EFFECT; DRUG SAFETY; DRUG SCREENING; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOGENICITY; MAJOR CLINICAL STUDY; MALE; NEISSERIA MENINGITIDIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT RESPONSE;

EID: 84866740317     PISSN: 00223476     EISSN: 10976833     Source Type: Journal    
DOI: 10.1016/j.jpeds.2012.04.005     Document Type: Article

References (24)

1. Revised recommendations of the Advisory Committee on Immunization Practices to Vaccinate all Persons Aged 11-18 Years with Meningococcal Conjugate Vaccine MMWR Morb Mortal Wkly Rep 56 2007 794 795
2. O.O. Bilukha, and N. Rosenstein Prevention and control of meningococcal disease. Recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm Rep 54 2005 1 21
3. S.A. Tasker, M.R. Wallace, J.B. Rubins, W.B. Paxton, J. O'Brien, and E.N. Janoff Reimmunization with 23-valent pneumococcal vaccine for patients infected with human immunodeficiency virus type 1: clinical, immunologic, and virologic responses Clin Infect Dis 34 2002 813 821 (Pubitemid 34194853)
4. M.J. Abzug, S.I. Pelton, L.Y. Song, T. Fenton, M.J. Levin, and S.A. Nachman Immunogenicity, safety, and predictors of response after a pneumococcal conjugate and pneumococcal polysaccharide vaccine series in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy Pediatr Infect Dis J 25 2006 920 929 (Pubitemid 44510587)
5. M.J. Abzug, M. Warshaw, H.M. Rosenblatt, M.J. Levin, S.A. Nachman, and S.I. Pelton Immunogenicity and immunologic memory after hepatitis B virus booster vaccination in HIV-infected children receiving highly active antiretroviral therapy J Infect Dis 200 2009 935 946
6. D. Gibb, A. Giacomelli, J. Masters, V. Spoulou, E. Ruga, and H. Griffiths Persistence of antibody responses to Haemophilus influenzae type b polysaccharide conjugate vaccine in children with vertically acquired human immunodeficiency virus infection Pediatr Infect Dis J 15 1996 1097 1101 (Pubitemid 27014701)
7. K.P. Klugman, S.A. Madhi, R.E. Huebner, R. Kohberger, N. Mbelle, and N. Pierce A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection N Engl J Med 349 2003 1341 1348 (Pubitemid 37186212)
8. M.J. Levin, A.A. Gershon, A. Weinberg, S. Blanchard, B. Nowak, and P. Palumbo Immunization of HIV-infected children with varicella vaccine J Pediatr 139 2001 305 310 (Pubitemid 32721722)
9. S.A. Madhi, P. Adrian, M.F. Cotton, J.A. McIntyre, P. Jean-Philippe, and S. Meadows Effect of HIV infection status and anti-retroviral treatment on quantitative and qualitative antibody responses to pneumococcal conjugate vaccine in infants J Infect Dis 202 2010 355 361
10. S.A. Madhi, L. Kuwanda, L. Saarinen, C. Cutland, R. Mothupi, and H. Kayhty Immunogenicity and effectiveness of Haemophilus influenzae type b conjugate vaccine in HIV infected and uninfected African children Vaccine 23 2005 5517 5525 (Pubitemid 41608600)
11. S.A. Madhi, K. Petersen, M. Khoosal, R.E. Huebner, N. Mbelle, and R. Mothupi Reduced effectiveness of Haemophilus influenzae type b conjugate vaccine in children with a high prevalence of human immunodeficiency virus type 1 infection Pediatr Infect Dis J 21 2002 315 321 (Pubitemid 34326870)
12. N. Mehta, C.K. Cunningham, P. Flynn, J. Pepe, S. Obaro, and B.G. Kapogiannis Impaired generation of hepatitis B virus-specific memory B cells in HIV infected individuals following vaccination Vaccine 28 2010 3672 3678
13. S. Nachman, S. Kim, J. King, E.J. Abrams, D. Margolis, and A. Petru Safety and immunogenicity of a heptavalent pneumococcal conjugate vaccine in infants with human immunodeficiency virus type 1 infection Pediatrics 112 2003 66 73 (Pubitemid 36792931)
14. S.K. Obaro, D. Pugatch, and K. Luzuriaga Immunogenicity and efficacy of childhood vaccines in HIV-1-infected children Lancet Infect Dis 4 2004 510 518 (Pubitemid 39077921)
15. J.S. Read, C.E. Frasch, K. Rich, G.A. Fitzgerald, J.D. Clemens, and J. Pitt The immunogenicity of Haemophilus influenzae type b conjugate vaccines in children born to human immunodeficiency virus-infected women. Women and Infants Transmission Study Group Pediatr Infect Dis J 17 1998 391 397 (Pubitemid 28232862)
16. A. Weinberg, P. Gona, S.A. Nachman, P. Defechereux, R. Yogev, and W. Hughes Antibody responses to hepatitis A virus vaccine in HIV-infected children with evidence of immunologic reconstitution while receiving highly active antiretroviral therapy J Infect Dis 193 2006 302 311 (Pubitemid 43113494)
17. G.K. Siberry, P.L. Williams, J. Lujan-Zilbermann, M.G. Warshaw, S.A. Spector, and M.D. Decker Phase I/II, open-label trial of safety and immunogenicity of meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine in human immunodeficiency virus-infected adolescents Pediatr Infect Dis J 29 2010 391 396
18. H. Keyserling, T. Papa, K. Koranyi, R. Ryall, E. Bassily, and M.J. Bybel Safety, immunogenicity, and immune memory of a novel meningococcal (groups A, C, Y, and W-135) polysaccharide diphtheria toxoid conjugate vaccine (MCV-4) in healthy adolescents Arch Pediatr Adolesc Med 159 2005 907 913 (Pubitemid 41423328)
19. C. Cohen, E. Singh, H.M. Wu, S. Martin, L. de Gouveia, and K.P. Klugman Increased incidence of meningococcal disease in HIV-infected individuals associated with higher case-fatality ratios in South Africa AIDS 24 2010 1351 1360
20. R. Borrow, H. Joseph, N. Andrews, M. Acuna, E. Longworth, and S. Martin Reduced antibody response to revaccination with meningococcal serogroup A polysaccharide vaccine in adults Vaccine 19 2000 1129 1132 (Pubitemid 32008278)
21. D.M. Granoff, and A.J. Pollard Reconsideration of the use of meningococcal polysaccharide vaccine Pediatr Infect Dis J 26 2007 716 722 (Pubitemid 47424642)
22. P. Richmond, E. Kaczmarski, R. Borrow, J. Findlow, S. Clark, and R. McCann Meningococcal C polysaccharide vaccine induces immunologic hyporesponsiveness in adults that is overcome by meningococcal C conjugate vaccine J Infect Dis 181 2000 761 764 (Pubitemid 30131856)
23. Updated recommendations for use of meningococcal conjugate vaccines - Advisory Committee on Immunization Practices (ACIP), 2010 MMWR Morb Mortal Wkly Rep 60 2011 72 76
24. R.B. Van Dyke, K. Patel, G.K. Siberry, S.K. Burchett, S.A. Spector, and M.C. Chernoff Antiretroviral treatment of US children with perinatally acquired HIV infection: temporal changes in therapy between 1991 and 2009 and predictors of immunologic and virologic outcomes J Acquir Immune Defic Syndr 57 2011 165 173